Dear Colleagues,

Please be informed the Impact Factor of our Official Journal “Hepatology International” is now 4.117!

APASL has been in existence since 1978 with the objective of unifying culture of diversity using the interest in Hepatology as a driving force to create a forum of advancement of science and discipline in Liver Health. It is my humble task to invite you to the Asian Pacific Association for the Study of the Liver Annual Convention in Manila, Philippine on February 20-24, 2019.

Soaring to New Heights in Hepatology embodies the thrust of the conference as it generates stimulating changes from highly effective drugs for treatment for liver cancer, cure for Hepatitis C, emerging therapies for Hepatitis B and other hepatitides as well as metabolic liver diseases. An assembly of over 50 countries from the Asian Pacific Region, APASL-MANILA aspires to bring together scientists, clinicians, students, other specialties and associates to discuss cutting edge technology in frontline of hepatology treatment merging with tools for digital exchange. Workshops were specifically designed to be a platform for exchange of ideas between mentors and mentee, Debate forum on ambiguous issues on treatment and management as well as Clinical Research forums featuring innovative concepts and techniques aimed at improving health care of patients with liver disease. Liver Tracks on Pathology, Radiology, Endoscopy, Surgery, Nutrition as well as Pediatrics will provide the framework of the growing landscape of Hepatology.

2019 APASL-MANILA is a distinct chance to interact, establish network, collaborate researches among the region with cultural diversity bound together with a single vision to improve patient care of those with Liver Diseases.

So JOIN, CONNECT and INTERACT with us in APASL-MANILA!

Dear Colleagues,

We are honored to invite you to the single topic conference on non responders that will be held in Istanbul on 27 to 29 September 2018. Such problems as the exposure of patients to cirrhosis of the liver, and its complications due to the unresponsiveness of chronic hepatitis B, C, and delta infections, to the current treatments; the development of hepatocellular carcinoma; and recurrence of infections following liver transplantation continue to be challenging issues in today’s world. New research with respect to patients with chronic hepatitis and who do not respond, specifically to the treatments specified in the treatment guidelines, will be presented, and interactive discussions will be held with the world’s opinion leaders on hepatology.

At the same time, the similarities and differences (if any) in terms of treatment between the East and the West will be debated. In particular, the steadily increasing trends in cirrhosis of the liver and hepatocellular cancer rates dependent on the unresponsiveness of the hepatitis C virus, between 2020-2030, will be confronted. For this reason, the treatment of compensated and/or decompensated cirrhosis of the liver being unresponsive or partially responsive to previous treatments or those developing dependent on relapses following treatment will continue to be a globally significant health problem.

Following the discovery of the Neolithic settlement during excavations in Yenikapı (the ancient port of Theodosius) it is now understood that the origins of Istanbul date back at least 8,500 years. The city of Istanbul was known as Byzantium by the Greeks in 700 BCE; as Constantinople it was the capital of the Roman and Eastern Roman Empires. Following the conquest of the city by the Ottoman Empire in 1453, the city remained the capital of the Ottoman Empire for almost five centuries, and was known to the Turks as Istanbul.

Among the most important monuments defining the culture and identity of the city are, the Hippodrome, the Basilica Cistern and the Column of Constantine date, which date from Roman times. Then there is the Galata Tower but by the Genoese, and of course, Haghia Sophia, which still stands as the most important testament to the Byzantine age in the world after 1500 years. Then there are the Ottoman buildings, such as the Topkapı Palace, for centuries the residence of the Ottoman sultans and the administrative center, together with more than 80 museums and 9 other Ottoman palaces. The Sultanahmet Mosque and Süleymaniye Mosque and superb examples of Ottoman religious architecture and the Grand Bazaar and Spice Market (Kapalıçarşı and Mısır Çarşısı), both still going strong today, continue the commercial tradition, for which Istanbul is so famous.

Istanbul’s cultural heritage has given the city international importance: in 2010 it was the European Capital of Culture and it is now included in the UNESCO World Heritage List. With its historical and natural beauties, bridges and underwater tunnel connecting the Asian and European continents, Istanbul shines like pearl on the Bosphorus.

Its ancient history and five centuries as the capital of the Ottoman Empire mean that alongside its own cultural wealth and culinary diversity, Istanbul embraces the illustrious cuisines of Asia, Europe and Africa. Turkish cuisine, now only second to Chinese in terms of popularity, celebrates its huge range of dishes, amazingly there are more than 400 varieties of dessert alone, and all of them are distinctive and delicious.

We would like to conclude by saying how We will be more than pleased to be your host in Istanbul, offering you the finest Traditional Ottoman Hospitality on the occasion of this scientifically rich program.

Kind regards,

Prof Dr Abdul Kadir Dokmeci
Honorary President of
APASL Single Topic Conference 2018 Istanbul

Prof Dr Necati Örmeci
President of
APASL Single Topic Conference 2018 Istanbul

---

---

---

---

---

---

---

---

---

---

---

Now the APASL Guidelines have been published in Hepatology International as follows!!!

APASL Guidelines for HBV -"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update" (Hepatol Int 2016; 10:1–98)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int 2016 10:681–701)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int 2016 10:702–726)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCC -”Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update” (Hepatol Int 2017; 11: 317-370)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)

*This APASL Guideline can be downloaded by clicking below.

APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int 2017 11:1–30)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)

*This APASL Guideline can be downloaded by clicking below.

The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2018 fellowship.

An application form can be downloaded by clicking here: http://apasl.info/applicationform-fellowship.docx Please fill in and send to the APASL secretariat (apasl_secretariat@apasl.info). We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.